English
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

Oral Oxycodone After Major Cardiac Surgery

Only registered users can translate articles
Log In/Sign up
The link is saved to the clipboard
StatusCompleted
Sponsors
Medical University of Vienna

Keywords

Abstract

Postoperative pain and analgesic treatment still remains a challenge in daily perioperative medicine. Skin incisions, intraoperative tissue retraction and -dissection, intravasal cannulations and drainages, sternotomy and pericardiotomy are the most important reasons for postoperative pain. Poorly controlled pain can contribute directly or indirectly to postoperative complications, such as myocardial ischemia, pulmonary dysfunction like hypoventilation, pneumonia and atelectasis, a delayed return of gastrointestinal function and decreased mobility. In addition, prolonged acute pain also results in chronic pain.
Opioids are internationally recognized as the golden standard in the treatment of acute postoperative pain. On one side, the high potency of opioids in pain relief is clearly undisputed, but on the other hand, the administration of opioids is associated with nausea, vomiting, sedation and with the development of bowel dysfunction, which encompasses symptoms including bloating, abdominal spasm, cramps and constipation. Opioid-induced constipation is a frequently reported adverse effect and sometimes requires discontinuation of therapy, which results in analgesic under-treatment, severely impairing quality of life. However, there are many different regimes for the treatment of postoperative pain using opioids. Patient-controlled analgesia (PCA) using morphine is widely used, but requires trained staff and expensive equipment. Once patients are able to tolerate oral medications, the oral route is preferred postoperatively because it is more convenient, noninvasive and less expensive.

Dates

Last Verified: 02/28/2014
First Submitted: 03/14/2013
Estimated Enrollment Submitted: 03/18/2013
First Posted: 03/21/2013
Last Update Submitted: 03/24/2014
Last Update Posted: 03/25/2014
Actual Study Start Date: 06/30/2011
Estimated Primary Completion Date: 04/30/2012
Estimated Study Completion Date: 02/28/2013

Condition or disease

Heart; Dysfunction Postoperative, Cardiac Surgery

Intervention/treatment

Drug: Targin/OxyNorm

Drug: Targin/OxyNorm

Drug: PCA

Phase

Phase 4

Arm Groups

ArmIntervention/treatment
Active Comparator: Targin/OxyNorm
Patients randomized to this study arm will receive Targin as basis pain medication and additional OxyNorm (Oxycodone), if requested by the patients.
Drug: Targin/OxyNorm
Active Comparator: PCA
Patients randomized to this group will receive a PCA pump with morphine. The basic rate is 0.3 mg/h. Patients will be allowed to administer 1 mg each five minutes after a vesting period of five minutes, if subjectively needed.
Drug: PCA

Eligibility Criteria

Ages Eligible for Study 18 Years To 18 Years
Sexes Eligible for StudyAll
Accepts Healthy VolunteersYes
Criteria

Inclusion Criteria:

- Age from 18 to 90 years

- ASA physical status 1-3

- Elective major cardiac surgery requiring sternotomy

- Oral and written consent

- Postoperative extubation within four hours after arrival at the ICU

- Cognitive ability in the use of the PCA pump and the VAS

Exclusion Criteria:

- Chronic use of opioids in the last three months

- Chronic use of tranquilizer or pain medications

- Hypersensitivity against opioids

- Use of monoamine oxidase inhibitors in the last two weeks before surgery

- Alcohol or drug abuse

- Renal dysfunction (GFR < 30 or necessity of dialysis)

- Liver Dysfunction defined as Child-Pugh-Score 7-15

- Ejection fraction (EF< 40%)

- Malabsorption syndrome

- Neurologic or cognitive dysfunction

- Pregnancy

- Participation in another clinical trial

- Severe respiratory depression with hypoxia and/or hypercapnia

- Severe chronic obstructive pulmonary disease

- Severe bronchial asthma

- Non-opioid induced paralytic ileus

- Risk of seizures

Outcome

Primary Outcome Measures

1. total opioid dosage in terms of so-called morphine equivalents [3 days]

total administrated opioid dosage during 3 days after surgery

Secondary Outcome Measures

1. VAS pain score [3 days]

Pain Scores on the Visual Analog Scale (0-100)

2. level of sedation [3 days]

Level of Sedation using the Ramsey Sedation Score.

3. rate of spontaneous breathing [3 days]

spontaneous breathing rate per minute

4. possible side effects [3 days]

open documentation of any side effects like dizziness, vomiting, allergic reaction

5. in hospital stay [1 month]

6. ICU stay [1 month]

Join our facebook page

The most complete medicinal herbs database backed by science

  • Works in 55 languages
  • Herbal cures backed by science
  • Herbs recognition by image
  • Interactive GPS map - tag herbs on location (coming soon)
  • Read scientific publications related to your search
  • Search medicinal herbs by their effects
  • Organize your interests and stay up do date with the news research, clinical trials and patents

Type a symptom or a disease and read about herbs that might help, type a herb and see diseases and symptoms it is used against.
*All information is based on published scientific research

Google Play badgeApp Store badge